Skip to main content
Top

Cardiac Regeneration in Adult Zebrafish: A Review of Signaling and Metabolic Coordination

  • 01-12-2025
  • Regenerative Medicine (SM Wu, Section Editor)
Published in:

Abstract

Purpose of Review

This review investigates how post-injury cellular signaling and energy metabolism are two pivotal points in zebrafish’s cardiomyocyte cell cycle re-entry and proliferation. It seeks to highlight the probable mechanism of action in proliferative cardiomyocytes compared to mammals and identify gaps in the current understanding of metabolic regulation of cardiac regeneration.

Recent Findings

Metabolic substrate changes after birth correlate with reduced cardiomyocyte proliferation in mammals. Unlike adult mammalian hearts, zebrafish can regenerate cardiomyocytes by re-entering the cell cycle, characterized by a metabolic switch from oxidative metabolism to increased glycolysis. Zebrafish provide a valuable model for studying metabolic regulation during cell cycle re-entry and cardiac regeneration. Proliferative cardiomyocytes have upregulated Notch, hippo, and Wnt signaling and decreased ROS generation, DNA damage in different zebrafish cardiac regeneration models. Understanding the correlation between metabolic switches during cell cycle re-entry of already differentiated zebrafish cardiomyocytes is being increasingly recognized as a critical factor in heart regeneration.

Summary

Zebrafish studies provide insights into metabolic adaptations during heart regeneration, emphasizing the importance of a metabolic switch. However, there are mechanistic gaps, and extensive studies are required to aid in formulating therapeutic strategies for cardiac regenerative medicine.
Title
Cardiac Regeneration in Adult Zebrafish: A Review of Signaling and Metabolic Coordination
Authors
Arkadeep Mitra
Subhadeep Mandal
Kalyan Banerjee
Nilanjan Ganguly
Pramit Sasmal
Durba Banerjee
Shreyasi Gupta
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 1/2025
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-024-02162-y
This content is only visible if you are logged in and have the appropriate permissions.

Other articles of this Issue 1/2025

The Weight of Comorbidities in the Specific Treatment of ATTR-Related Amyloid Cardiomyopathy

  • Open Access
  • Heart Failure
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

The Impact of Federal and State Laws on Cardiovascular Risk

  • Open Access
  • Diversity and Health Equity in Cardiology (AE Johnson, Section Editor)

The Ross Procedure: Historical Context, Modern Outcomes, and the Road Ahead

Transcatheter Structural Heart Interventions in Women

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME